Details for New Drug Application (NDA): 021260
✉ Email this page to a colleague
The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 021260
Tradename: | AVINZA |
Applicant: | King Pharms Llc |
Ingredient: | morphine sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021260
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
Approval Date: | Mar 20, 2002 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 60MG | ||||
Approval Date: | Mar 20, 2002 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 90MG | ||||
Approval Date: | Mar 20, 2002 | TE: | RLD: | No |
Expired US Patents for NDA 021260
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | AVINZA | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260-003 | Mar 20, 2002 | 6,066,339 | ⤷ Subscribe |
King Pharms Llc | AVINZA | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260-001 | Mar 20, 2002 | 6,066,339 | ⤷ Subscribe |
King Pharms Llc | AVINZA | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260-004 | Mar 20, 2002 | 6,066,339 | ⤷ Subscribe |
King Pharms Llc | AVINZA | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260-006 | Dec 18, 2008 | 6,066,339 | ⤷ Subscribe |
King Pharms Llc | AVINZA | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 021260-002 | Mar 20, 2002 | 6,066,339 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription